Search results
Results from the WOW.Com Content Network
William K. Oh, is an American medical oncologist, academic leader and expert in the management of prostate cancer. He has also held leadership roles in industry and non-profits, including as Chair of the American Cancer Society ’s National Prostate Cancer Roundtable.
The Yale School of Medicine is the medical school of Yale University, a private research university in New Haven, Connecticut. It was founded in 1810 as the Medical Institution of Yale College and formally opened in 1813. [1] It is the sixth-oldest medical school in the United States. [2] The school’s faculty clinical practice is Yale Medicine.
In the 1970s, a longstanding relationship with Yale School of Medicine was formalized, enhancing St. Raphael's role as a community teaching hospital. The Verdi Memorial Building opened in 1976, which expanded and improved upon the hospital's surgical, emergency, and intensive care services.
Akiko Iwasaki (岩崎明子, Iwasaki Akiko, born September 13, 1970) is a Sterling Professor of Immunobiology and Molecular, Cellular and Developmental Biology at Yale University. [1] She is also a principal investigator at the Howard Hughes Medical Institute. [2]
Lisa Sanders (born July 24, 1956) is an American physician, medical author and journalist, and associate professor of internal medicine and education at Yale School of Medicine. In 2002, she began writing a column for The New York Times called Diagnosis, that covered medical mystery cases. She is an attending physician at Yale-New Haven Hospital.
William Mark Saltzman was named the Goizueta Foundation Professor of Biomedical and Chemical Engineering at Yale University on July 1, 2002 and became the founding chair of Yale's Department of Biomedical Engineering in 2003. [1] Saltzman's research aims to promote new methods for drug delivery and develop new biotechnologies to combat human ...
William Pao (born 1967) is an oncologist and Executive Vice President and Chief Development Officer of Pfizer. [1] He was previously the head of Pharma Research and Early Development (pRED) at Roche and a professor of medicine at the Vanderbilt University Medical Center. He is best known for his work in molecular oncology and cancer genomics. [2]
Yale School of Medicine was home to the country’s first university-based Medical Oncology Section, and its faculty has since pioneered many breakthrough cancer treatments. [5] Basic research in cancer is a hallmark of Yale Cancer Center, which draws approximately $96 million in cancer research funding to Yale every year. [7]